SCHEMBL7962836

SCHEMBL7962836

Cc1cc(/C=C(\C#N)S(=O)(=O)c2ccc(C(F)(F)F)cc2)cc(C)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.47
PKM P14618 3/20 0.47
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
POLB P06746 1/20 0.46
GAA P10253 1/20 0.46
ALPG P10696 1/20 0.46
ALOX15 P16050 1/20 0.46
ALOX12 P18054 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
BRD4 O60885 2/20 0.44
EGFR P00533 4/20 0.39
ERBB2 P04626 1/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7962839 1.00 HPGD (0.47) HPGDPKMALDH1A1KDM4EL3MBTL1
SCHEMBL7962841 1.00 HPGD (0.47) HPGDPKMALDH1A1KDM4EL3MBTL1
SCHEMBL7963603 0.87 HPGD (0.46) HPGDPKMALDH1A1KDM4EL3MBTL1
SCHEMBL7963599 0.87 HPGD (0.46) HPGDPKMALDH1A1KDM4EL3MBTL1
SCHEMBL7963601 0.87 HPGD (0.46) HPGDPKMALDH1A1KDM4EL3MBTL1
SCHEMBL7952026 0.86 PKM (0.61) HPGDPKMALDH1A1KDM4EL3MBTL1
SCHEMBL7952025 0.86 PKM (0.61) HPGDPKMALDH1A1KDM4EL3MBTL1
SCHEMBL7952024 0.86 PKM (0.61) HPGDPKMALDH1A1KDM4EL3MBTL1
SCHEMBL7962106 0.86 HPGD (0.49) HPGDPKMALDH1A1KDM4EL3MBTL1
SCHEMBL7962102 0.86 HPGD (0.49) HPGDPKMALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed